S O Warnaar - JoVE Visualize

Showing results (41-50 of 69) with videos related to

Pageof 7

Sort By:

Cancer Research|October 1, 1995

Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma modelM P Velders, C M van Rhijn, I H Briaire, et al.

Molecular and Cellular Biology|July 22, 1998

Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion moleculeM Balzar, H A Bakker, I H Briaire-de-Bruijn, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993

Clustered CD3/TCR complexes do not transduce activation signals after bispecific monoclonal antibody-triggered lysis by cytotoxic T lymphocytes via CD3C J Blank-Voorthuis, E Braakman, C P Ronteltap, et al.

Experimental Cell Research|January 1, 1986

Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13G N van Muijen, D J Ruiter, W W Franke, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1988

Perfusion of tumor-bearing kidneys as a model for scintigraphic screening of monoclonal antibodiesJ van Dijk, E Oosterwijk, M J van Kroonenburgh, et al.

Leukemia & Lymphoma|January 28, 1999

Blocking interleukin-6 activity with chimeric anti-IL6 monoclonal antibodies in multiple myeloma: effects on soluble IL6 receptor and soluble gp130H C Van Zaanen, H M Lokhorst, L A Aarden, et al.

Cancer Research|April 1, 1994

New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potencyM P Velders, S V Litvinov, S O Warnaar, et al.

Cancer|May 1, 1979

On the presence of reverse transcriptase in myelo- and lymphoproliferative disordersG N van Muijen, J te Velde, G J den Ottolander, et al.

Human Antibodies|January 1, 1997

Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cellsR M Luiten, S O Warnaar, J Schuurman, et al.

International Journal of Cancer|August 19, 1993

Analysis of production, purification, and cytolytic potential of bi-specific antibodies reactive with ovarian-carcinoma-associated antigens and the T-cell antigen CD3H H van Ravenswaay Claasen, R J van de Griend, D Mezzanzanica, et al.

Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:

Pageof 7

Cancer Research|October 1, 1995

Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma modelM P Velders, C M van Rhijn, I H Briaire, et al.

Molecular and Cellular Biology|July 22, 1998

Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion moleculeM Balzar, H A Bakker, I H Briaire-de-Bruijn, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993

Clustered CD3/TCR complexes do not transduce activation signals after bispecific monoclonal antibody-triggered lysis by cytotoxic T lymphocytes via CD3C J Blank-Voorthuis, E Braakman, C P Ronteltap, et al.

Experimental Cell Research|January 1, 1986

Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13G N van Muijen, D J Ruiter, W W Franke, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1988

Perfusion of tumor-bearing kidneys as a model for scintigraphic screening of monoclonal antibodiesJ van Dijk, E Oosterwijk, M J van Kroonenburgh, et al.

Leukemia & Lymphoma|January 28, 1999

Blocking interleukin-6 activity with chimeric anti-IL6 monoclonal antibodies in multiple myeloma: effects on soluble IL6 receptor and soluble gp130H C Van Zaanen, H M Lokhorst, L A Aarden, et al.

Cancer Research|April 1, 1994

New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potencyM P Velders, S V Litvinov, S O Warnaar, et al.

Cancer|May 1, 1979

On the presence of reverse transcriptase in myelo- and lymphoproliferative disordersG N van Muijen, J te Velde, G J den Ottolander, et al.

Human Antibodies|January 1, 1997

Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cellsR M Luiten, S O Warnaar, J Schuurman, et al.

International Journal of Cancer|August 19, 1993

Analysis of production, purification, and cytolytic potential of bi-specific antibodies reactive with ovarian-carcinoma-associated antigens and the T-cell antigen CD3H H van Ravenswaay Claasen, R J van de Griend, D Mezzanzanica, et al.

Pageof 7